Related Experiment Video
Updated: Mar 22, 2026

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
Published on: July 3, 2015
Lysosomal down-regulation of the mu opioid receptor is opposed by the Retromer complex
Aleksandra Dagunts1, Hayden Adoff1, Brandon Novy1
1Department of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, OR 97239, USA.
Abstract:
A critical homeostatic mechanism for regulating G protein-coupled receptor (GPCR) activity is agonist-induced GPCR endocytosis and trafficking to the lysosome for proteolytic down-regulation. The mu opioid receptor (MOR) is a notable example of this type of cellular regulation, where prolonged exposure to high-efficacy opioid drugs causes MOR to traffic to the lysosome. Here, we used functional genomics to identify cellular proteins that control MOR lysosomal down-regulation. We found that the central regulator of MOR postendocytic trafficking is the Retromer complex, which rescues MOR from opioid-induced down-regulation by promoting MOR recycling from endosomes to the plasma membrane. Critically, MOR accesses the Retromer recycling pathway through its noncanonical bileucine recycling motif, and this mechanism controls how MOR is regulated following chronic exposure to opioid drugs. Additionally, we show that this bileucine pathway for Retromer-based recycling is present in other classes of membrane proteins including the glucose transporter GLUT4.
Insights
The Retromer complex recycles the mu opioid receptor (MOR) from endosomes, preventing its lysosomal down-regulation. This bileucine motif pathway is crucial for regulating MOR activity and is also found in other membrane proteins like GLUT4.
Area of Science:
- Cell Biology
- Molecular Pharmacology
- Biochemistry
Background:
- G protein-coupled receptors (GPCRs) are regulated by agonist-induced endocytosis and lysosomal degradation.
- The mu opioid receptor (MOR) undergoes lysosomal trafficking upon prolonged exposure to high-efficacy opioid drugs.
Purpose of the Study:
- To identify cellular proteins controlling MOR lysosomal down-regulation.
- To elucidate the mechanism by which MOR trafficking is regulated.
Main Methods:
- Functional genomics screens were employed to identify key regulatory proteins.
- Postendocytic trafficking pathways of MOR were investigated.
Main Results:
- The Retromer complex was identified as a central regulator of MOR postendocytic trafficking.
- Retromer promotes MOR recycling from endosomes to the plasma membrane, rescuing it from lysosomal down-regulation.
- MOR utilizes a noncanonical bileucine recycling motif to access the Retromer pathway.
- This bileucine-mediated Retromer recycling pathway is also observed in other membrane proteins, such as GLUT4.
Conclusions:
- The Retromer complex, via a bileucine motif, plays a critical role in preventing MOR lysosomal down-regulation.
- This mechanism provides a novel insight into the regulation of GPCRs and other membrane proteins, impacting cellular homeostasis and drug response.
More Related Videos
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
10:16SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry
Published on: January 6, 2017
Related Concept Videos
Opioid Receptors: Overview
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Analgesia and Pain Management
GPCR Desensitization
Export of Misfolded Proteins out of the ER
Opioid Analgesics: Synthetic and Semisynthetic Opioids